Literature DB >> 8496589

Activation of CD8-dependent cytotoxic T lymphocyte adhesion and degranulation by peptide class I antigen complexes.

K P Kane1, M F Mescher.   

Abstract

Activation of CTL requires engagement of both the TCR and the CD8 coreceptor. Immobilized class I proteins and in vitro-formed peptide class I Ag complexes have been used to examine the relative contributions of TCR and CD8 to the adhesion and response of cloned, class I-restricted CTL. The extent of degranulation was found to be directly proportional to the concentration of peptide used to pulse class I, suggesting that activation is a direct function of TCR occupancy level. In contrast, activation of degranulation as a function of the amount of class I on the surface displayed a marked threshold density dependence. Essentially the same density dependence was found for the response of CTL to fluid phase anti-TCR mAb and non-Ag class I, indicating that CD8-class I interaction must exceed a threshold before effective cosignaling can occur. Adhesion and degranulation of CTL was minimal in response to in vitro peptide-class I complexes prepared at a class I density below the threshold. However, the same density of peptide class I initiated both adhesion and response if additional non-Ag class I was coimmobilized on the same surface at levels above threshold. Thus, when surface levels of peptide class I complex are low, as is likely to be the case under physiologic conditions, the level of TCR occupancy achieved is, by itself, insufficient to mediate cell adhesion or activate degranulation. The results demonstrate, however, that low TCR occupancy is sufficient to provide the signal to prime CD8. Provided that the surface density of class I is sufficiently high, CD8 then mediates strong adhesion and provides the costimulatory signal(s) to activate response.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496589

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Peptide engineering allows cytotoxic T-cell vaccination against human papilloma virus tumour antigen, E6.

Authors:  G B Lipford; S Bauer; H Wagner; K Heeg
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

2.  Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.

Authors:  S Pion; P Fontaine; C Baron; M Gyger; C Perreault
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

3.  Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.

Authors:  B M Kessler; P Bassanini; J C Cerottini; I F Luescher
Journal:  J Exp Med       Date:  1997-02-17       Impact factor: 14.307

4.  Role of CD8 in aberrant function of cytotoxic T lymphocytes.

Authors:  B Kessler; D Hudrisier; J C Cerottini; I F Luescher
Journal:  J Exp Med       Date:  1997-12-15       Impact factor: 14.307

5.  Differential ability of isolated H-2 Kb subsets to serve as TCR ligands for allo-specific CTL clones: potential role for N-linked glycosylation.

Authors:  L Shen; K P Kane
Journal:  J Exp Med       Date:  1995-05-01       Impact factor: 14.307

6.  Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.

Authors:  L Shen; T A Potter; K P Kane
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  T cell activation is determined by the number of presented antigens.

Authors:  Janosch Deeg; Markus Axmann; Jovana Matic; Anastasia Liapis; David Depoil; Jehan Afrose; Silvia Curado; Michael L Dustin; Joachim P Spatz
Journal:  Nano Lett       Date:  2013-10-17       Impact factor: 11.189

8.  Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection.

Authors:  Ali Sakhdari; Shariq Mujib; Bahareh Vali; Feng Yun Yue; Sonya MacParland; Kiera Clayton; Richard Bradley Jones; Jun Liu; Erika Yue Lee; Erika Benko; Colin Kovacs; Jennifer Gommerman; Rupert Kaul; Mario A Ostrowski
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

9.  The murine nonclassical class I major histocompatibility complex-like CD1.1 molecule protects target cells from lymphokine-activated killer cell cytolysis.

Authors:  C S Chang; L Brossay; M Kronenberg; K P Kane
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.